ZIMLAB137.20

Zim Laboratories Limited

· Pharma & Health
₹ CrorePeersANUHPHRVALIANTLABAHCLALBERTDAVDWANBURYHALEOSLABSBAJAJHCARETHEMISMEDMcap ₹734 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment156.9158.3156.4156.4
+ Capital Work-in-Progress23.544.158.858.8
+ Goodwill0.20.20.20.2
+ Other Intangibles3.75.85.25.2
+ Intangibles under Development18.826.436.836.8
+ Non-current Investments0.10.10.10.1
+ Other Non-current Financial Assets0.81.03.53.5
Non-current Financial Assets0.81.13.63.6
+ Deferred Tax Assets0.00.00.50.5
+ Other Non-current Assets15.24.92.22.2
Total Non-current Assets219.2240.7263.6263.6
Current Assets
+ Inventories81.386.593.893.8
+ Trade Receivables100.2106.9109.0109.0
+ Cash & Cash Equivalents9.61.925.125.1
+ Other Bank Balances0.90.518.318.3
+ Other Current Financial Assets0.30.30.50.5
Current Financial Assets110.9109.7152.9152.9
+ Other Current Assets35.435.129.129.1
Total Current Assets227.6231.3275.8275.8
Total Assets446.8472.0539.4539.4
Equity
+ Equity Share Capital48.748.753.553.5
+ Other Equity / Reserves190.0203.5242.7242.7
Equity — Owners of Parent238.7252.2296.2296.2
+ Minority Interest0.00.00.00.0
Total Equity238.7252.2296.2296.2
Liabilities
+ Borrowings — Non-current35.640.341.641.6
+ Other Non-current Financial Liab2.92.10.80.8
Non-current Financial Liabilities38.642.442.442.4
+ Deferred Tax Liabilities10.111.110.410.4
Non-current Liabilities48.753.452.852.8
+ Borrowings — Current70.871.981.481.4
+ Trade Payables62.469.572.972.9
+ Other Current Financial Liab13.215.313.413.4
Current Financial Liabilities146.4156.6167.8167.8
+ Provisions — Current0.80.70.90.9
+ Current Tax Liabilities0.02.92.62.6
+ Other Current Liabilities12.26.119.219.2
Current Liabilities159.4166.4190.4190.4
Total Liabilities208.1219.8243.2243.2
Total Equity & Liabilities446.8472.0539.4539.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current6.78.58.5
+ Dues to Other Creditors — Current62.864.564.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.